MetLife Investment Management’s Innodata INOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$670K Sell
17,337
-136
-0.8% -$6.78K ﹤0.01% 1615
2025
Q4
$890K Sell
17,473
-622
-3% -$40.6K ﹤0.01% 1494
2025
Q3
$1.39M Hold
18,095
0.01% 1271
2025
Q2
$927K Buy
18,095
+1,959
+12% +$77.3K 0.01% 1356
2025
Q1
$579K Sell
16,136
-278
-2% -$12.2K ﹤0.01% 1656
2024
Q4
$649K Buy
16,414
+1,776
+12% +$56K ﹤0.01% 1652
2024
Q3
$245K Hold
14,638
﹤0.01% 2179
2024
Q2
$217K Buy
14,638
+7,901
+117% +$82.1K ﹤0.01% 2192
2024
Q1
$44.5K Sell
6,737
-6,608
-50% -$54.9K ﹤0.01% 2725
2023
Q4
$109K Hold
13,345
﹤0.01% 2571
2023
Q3
$114K Hold
13,345
﹤0.01% 2516
2023
Q2
$151K Buy
+13,345
New +$124K ﹤0.01% 2436

Other funds holding INOD

MetLife Investment Management's INOD Position: Q1 2026 in Review

MetLife Investment Management reduced its Innodata (INOD) stake by 0.78% in Q1 2026, selling an estimated $6.78K and leaving 17,337 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #1615.

MetLife Investment Management first reported a position in INOD in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.39M in Q3 2025. 229 funds tracked by Wall St. Rank hold INOD as of Q1 2026.

  • MetLife Investment Management held 17,337 shares of Innodata worth $670K as of Q1 2026.
  • MetLife Investment Management sold 136 Innodata shares in Q1 2026, an estimated $6.78K.
  • Innodata made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1615 holding.
  • MetLife Investment Management first reported a position in Innodata in Q2 2023 and has held it in 12 quarters since.
  • MetLife Investment Management's Innodata position peaked at $1.39M in Q3 2025.
  • 229 funds tracked by Wall St. Rank held Innodata as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.